383 related articles for article (PubMed ID: 28591133)
61. A randomized, double-blind, placebo-controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women.
Haines CJ; Lam PM; Chung TK; Cheng KF; Leung PC
Climacteric; 2008 Jun; 11(3):244-51. PubMed ID: 18568789
[TBL] [Abstract][Full Text] [Related]
62. A cross-sectional study of equol producer status and self-reported vasomotor symptoms.
Newton KM; Reed SD; Uchiyama S; Qu C; Ueno T; Iwashita S; Gunderson G; Fuller S; Lampe JW
Menopause; 2015 May; 22(5):489-95. PubMed ID: 25380274
[TBL] [Abstract][Full Text] [Related]
63. Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials.
Cano A; Nappi RE; Santoro N; Stute P; Blogg M; English ML; Morga A; Scrine L; Siddiqui E; Ottery FD
BJOG; 2024 Aug; 131(9):1296-1305. PubMed ID: 38320967
[TBL] [Abstract][Full Text] [Related]
64. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
[TBL] [Abstract][Full Text] [Related]
65. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial.
Reddy SY; Warner H; Guttuso T; Messing S; DiGrazio W; Thornburg L; Guzick DS
Obstet Gynecol; 2006 Jul; 108(1):41-8. PubMed ID: 16816054
[TBL] [Abstract][Full Text] [Related]
66. Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial.
Crawford SL; Jackson EA; Churchill L; Lampe JW; Leung K; Ockene JK
Menopause; 2013 Sep; 20(9):936-45. PubMed ID: 23511704
[TBL] [Abstract][Full Text] [Related]
67. Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial.
Hattersley G; Harris AG; Simon JA; Constantine GD
Menopause; 2017 Jan; 24(1):92-99. PubMed ID: 27575546
[TBL] [Abstract][Full Text] [Related]
68. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
Randolph JF; Sowers M; Bondarenko I; Gold EB; Greendale GA; Bromberger JT; Brockwell SE; Matthews KA
J Clin Endocrinol Metab; 2005 Nov; 90(11):6106-12. PubMed ID: 16144949
[TBL] [Abstract][Full Text] [Related]
69. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
[TBL] [Abstract][Full Text] [Related]
70. Efficacy of a Proprietary Trigonella foenum-graecum L. De-Husked Seed Extract in Reducing Menopausal Symptoms in Otherwise Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Study.
Steels E; Steele ML; Harold M; Coulson S
Phytother Res; 2017 Sep; 31(9):1316-1322. PubMed ID: 28707431
[TBL] [Abstract][Full Text] [Related]
71. Dietary Supplementation of Myo-Inositol, Cocoa Polyphenols, and Soy Isoflavones Improves Vasomotor Symptoms and Metabolic Profile in Menopausal Women with Metabolic Syndrome: A Retrospective Clinical Study.
Mainini G; Ercolano S; De Simone R; Iavarone I; Lizza R; Passaro M
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674244
[No Abstract] [Full Text] [Related]
72. The effect of Promensil, an isoflavone extract, on menopausal symptoms.
Knight DC; Howes JB; Eden JA
Climacteric; 1999 Jun; 2(2):79-84. PubMed ID: 11910671
[TBL] [Abstract][Full Text] [Related]
73. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause.
Archer DF; Seidman L; Constantine GD; Pickar JH; Olivier S
Am J Obstet Gynecol; 2009 Feb; 200(2):172.e1-10. PubMed ID: 19110224
[TBL] [Abstract][Full Text] [Related]
74. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
Pinkerton JV; Constantine G; Hwang E; Cheng RF;
Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
[TBL] [Abstract][Full Text] [Related]
75. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.
Levis S; Strickman-Stein N; Doerge DR; Krischer J
Contemp Clin Trials; 2010 Jul; 31(4):293-302. PubMed ID: 20230914
[TBL] [Abstract][Full Text] [Related]
76. Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.
Hitchcock CL; Prior JC
Menopause; 2012 Aug; 19(8):886-93. PubMed ID: 22453200
[TBL] [Abstract][Full Text] [Related]
77. Clinical effects of a proprietary combination isoflavone nutritional supplement in menopausal women: a pilot trial.
Lukaczer D; Darland G; Tripp M; Liska D; Lerman RH; Schiltz B; Bland JS
Altern Ther Health Med; 2005; 11(5):60-5. PubMed ID: 16189949
[TBL] [Abstract][Full Text] [Related]
78. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women.
Stevens RE; Hanford K; Wason S; Cusack SL; Phelps KV
Int J Fertil Womens Med; 2000; 45(4):264-72. PubMed ID: 10997482
[TBL] [Abstract][Full Text] [Related]
79. Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters.
Pinkerton JV; Abraham L; Bushmakin AG; Cappelleri JC; Komm BS
Menopause; 2016 Oct; 23(10):1060-6. PubMed ID: 27404028
[TBL] [Abstract][Full Text] [Related]
80. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
